Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00592748 · ClinicalTrials.gov registry record · Phase 1
Charged Particle RT for Chordomas and Chondrosarcomas of the Base of Skull or Cervical Spine
A Phase 1 study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- Phase 1
- Development phase
- 381
- Enrollment target
NCT00592748: Completed Phase 1 study, sponsored by Massachusetts General Hospital.
NCT00592748 is a Phase 1 study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 381 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00592748, a Phase 1 study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 381 participants
- Enrollment target
Study Summary
The primary purpose of this study is to determine if the administration of a higher dose would decrease the chance of tumor recurrence, compared to the risk of tumor recurrence with a lower dose. Most of the treatment will be given protons, but participants may receive a small portion of treatment with x-rays, because less radiation is given to the skin with x-rays. This study uses two slightly different doses of radiation It is not clear at this time which of the dose levels is better.
Interventions
- RADIATION Charged Particle Radiation Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 381 participants |
| Start Date | 1999-06 |
| Est. Completion | 2015-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00592748
The ClinicalTrials.gov registry entry for NCT00592748 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 381 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Charged Particle Radiation Therapy is the first listed.
NCT00592748 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00592748 about?
NCT00592748 is a clinical study titled "Charged Particle RT for Chordomas and Chondrosarcomas of the Base of Skull or Cervical Spine". The primary purpose of this study is to determine if the administration of a higher dose would decrease the chance of tumor recurrence, compared to the risk of tumor recurrence with a lower dose. Most of the treatment will be given protons, but participants may receive a small portion of treatment w...
What is the current status of trial NCT00592748?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 381 participants. The study started on 1999-06. Estimated completion is 2015-05.
What interventions are being tested in trial NCT00592748?
The interventions under investigation include: Charged Particle Radiation Therapy (RADIATION).
Who is sponsoring clinical trial NCT00592748?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.